MERIT MEDICAL SYSTEMS INC (MMSI) Form 10-Q — Oct 29, 2026
Merit Medical Systems reported Q3 2026 net sales of $416.2 million, up 8.4% year over year, with net income rising to $42.3 million ($0.70 diluted EPS) from $27.8 million ($0.46) a year ago. Nine-month revenue reached $1,217.0 million, up 8.5%, with diluted EPS of $2.03 versus $1.49. The company holds $505.8 million in cash and restricted cash plus $697 million of available revolver capacity, against $747.5 million of 3.00% convertible notes due February 2029. It was in compliance with all credit agreement covenants as of September 30, 2026.
Key figures
- Eps
- 0.7
- Revenue
- 416244000
- Net Income
- 42311000
- Total Debt
- 747500000
- Revenue Yoy
- 8.4%
- Total Assets
- 2924906000
- Cash Position
- 505787000
- Shares Outstanding
- 59915044
- Gross margin q3
- 48.2%
- Q3 2025 revenue
- 384157000
- Nine month revenue
- 1216964000
- Q3 2025 net income
- 27755000
- Revolver available
- 697000000
- View point upfront
- 90000000
- Nine month net income
- 122109000
- Convertible notes rate
- 3.00%
- Nine month diluted eps
- 2.03
- Nine month revenue yoy
- 8.5%
- Dualcap divestiture gain
- 12500000
- Convertible notes maturity
- 2029-02-01
- Solo pace acquisition upfront
- 45000000
- Operating cash flow nine months
- 175230000
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.